<DOC>
	<DOCNO>NCT01392118</DOCNO>
	<brief_summary>The purpose study investigate risk factor , molecular character susceptibility change recurrent ESBL-producing Enterobacteriaceae bacteremia</brief_summary>
	<brief_title>Recurrent ESBL-producing Enterobacteriaceae Bacteremia : Risk Factor , Molecular Character Susceptibility Change</brief_title>
	<detailed_description>1 . To characterize genotype pathogen isolated recurrent ESBL-EK bacteremia versus non-recurrent ESBL-EK bacteremia differentiate relapse reinfection - recurrent versus non-recurrent - relapse versus reinfection 2 . To correlate patient characteristic , clinical manifestation , severity illness ( modify Pitt bacteremia score ) , diagnosis deep-site infection , co-morbid condition ( include diabetes mellitus , hepatic renal dysfunction ) , length stay ICU/hospitalization , presence invasive procedure , source pathogen ( community acquire nosocomial infection ) , antimicrobial regimen ( i.e carbapenems versus non-carbapenems ( flomoxef quinolones ) , microbiological characteristic ( E coli Kleb . pneumoniae ) outcome endpoint ( clinical outcome mortality ) ESBL recurrence genotype</detailed_description>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<criteria>Adult patient ( age &gt; =18 year ) least one episode ESBLEK bloodstream infection August 2004 July 2010 Patients die within 48h first episode ESBLEK bloodstream infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>